Efficacy and safety of Rasagiline in levodopa-treated Korean Parkinson's disease patients with motor fluctuations: Randomized, placebo-controlled, double-blind study

被引：0
作者：
Yun, Ji Young
Jeon, Beom
Kim, Jae Woo
Lee, Chong
Kim, Jong-Min
Cho, Jin Whan
Sohn, Young
Lee, Jee-Young
机构：
来源：
MOVEMENT DISORDERS | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
55
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
[31]   Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial [J].
Wolz, Martin ;
Lohle, Matthias ;
Strecker, Karl ;
Schwanebeck, Uta ;
Schneider, Christine ;
Reichmann, Heinz ;
Graehlert, Xina ;
Schwarz, Johannes ;
Storch, Alexander .
JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (11) :1279-1286
[32]   MODERATO, a randomized, double-blind, placebo-controlled study to assess the effect of rasagiline on mild cognitive impairment in patients with Parkinson's disease: An ongoing study [J].
Choudhry, A. ;
Weintraub, D. ;
Hauser, R. A. .
MOVEMENT DISORDERS, 2014, 29 :S231-S231
[33]   Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study [J].
Lou, JS ;
Kearns, G ;
Benice, T ;
Oken, B ;
Sexton, G ;
Nutt, J .
MOVEMENT DISORDERS, 2003, 18 (10) :1108-1114
[34]   A Randomized, Double-Blind, Placebo-Controlled Trial of Camicinal in Parkinson's Disease [J].
Marrinan, Sarah L. ;
Otiker, Tal ;
Vasist, Lakshmi S. ;
Gibson, Rachel A. ;
Sarai, Bhopinder K. ;
Barton, Matthew E. ;
Richards, Duncan B. ;
Hellstrom, Per M. ;
Nyholm, Dag ;
Dukes, George E. ;
Burn, David J. .
MOVEMENT DISORDERS, 2018, 33 (02) :329-332
[35]   Selegiline reduced tremor and bradykinesia in levodopa-treated Parkinson's disease patients in a long-term randomized double-blind study [J].
Pålhagen, SE .
MOVEMENT DISORDERS, 2005, 20 :S125-S125
[36]   A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease [J].
Yokoyama, Shunichi ;
Yoshinaga, Takuma ;
Matsuzaki, Juntaro ;
Suzuki, Hidekazu .
JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) :1187-1199
[37]   Efficacy and safety of rasagiline as an adjunct to levodopa treatment in Chinese patients with Parkinson's disease: a randomized, double-blind, parallel-controlled, multi-centre trial [J].
Zhang, Lina ;
Zhang, Zhiqin ;
Chen, Yangmei ;
Qin, Xinyue ;
Zhou, Huadong ;
Zhang, Chaodong ;
Sun, Hongbin ;
Tang, Ronghua ;
Zheng, Jinou ;
Yi, Lin ;
Deng, Liying ;
Li, Jinfang .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (07) :1529-1537
[38]   Efficacy of opicapone in Parkinson's disease patients with motor fluctuations: A phase III, randomized, double-blind, placebo and active-controlled study - BIPARK I [J].
Ferreira, J. ;
Lees, A. ;
Santos, A. ;
Pinto, R. ;
Lopes, N. ;
Nunes, T. ;
Rocha, J. F. ;
Soares-da-Silva, P. .
MOVEMENT DISORDERS, 2015, 30 :S85-S86
[39]   Safety and tolerability of tyramine challenge in levodopa-treated Parkinson's disease (PD) patients receiving rasagiline [J].
Wilkinson, Jayne ;
Reichwein, Suzanne ;
Stern, Matthew .
NEUROLOGY, 2008, 70 (11) :A58-A59
[40]   Safety and Tolerability of Once-Daily Opicapone in Patients with Parkinson's Disease and Motor Fluctuations: Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Studies [J].
Kremens, Daniel ;
Poewe, Werner ;
Rascol, Olivier ;
Olson, Kurt ;
Farahmand, Khodayar ;
Siegert, Scott ;
McMicken, Carolyn ;
Rocha, Jose-Francisco ;
Soares-da-Silva, Patricio ;
Liang, Grace S. .
ANNALS OF NEUROLOGY, 2019, 86 :S84-S84
12345